Kohl’s Faces Fresh Downgrades From Goldman, JPMorgan
Goldman Sachs and JPMorgan cut targets on Kohl’s as consumer demand cools, signaling a tougher 2026. The moves come a...
When To Adjust Your Financial Plan
Knowing when to adjust your financial plan can significantly impact your financial success. Learn key indicators for making timely adjustments.
23,637 articlesAtlassian Price Prediction: Down Drives Investor Caution
Atlassian shares remain under pressure as the company drives cost cuts and pivots to a cloud-focused model. Analysts ...
Safest Dividend Kings Only: 5 Stocks to Buy Now
As markets wobble in 2026, five stalwarts stand out for reliable income and resilience. Here are the safest dividend ...
Best Stocks Under $10: Fresh Picks for 2026 Market
As market volatility persists in March 2026, traders are eyeing best stocks under $10 for potential gains. The group ...
Waymo Co-CEO Insists Robotaxis Aren’t Job Killers
Waymo’s leadership argues that robotaxis will reframe work rather than eliminate it, highlighting maintenance, fleet ...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Microsoft’s Troubled Problems Just Deepen for Investors
microsoft’s troubled problems just intensified as Microsoft restructures its AI operation amid mounting competitive p...
South Korea Opposition Moves to Abolish Crypto Tax
South Korea faces a major shift as lawmakers push to abolish the crypto capital gains tax amid a dramatic capital fli...
Super Micro Risks Removal Triggers S&P 500 Shakeup
Super Micro Computer faces a looming risk of removal from the S&P 500 after prosecutors charged its co-founder and tw...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
High-Yield International ETFs Beating the S&P 500 This Year
A quartet of high-yield international ETFs has posted stronger returns than the S&P 500 over the past year, deliverin...
Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status